HK1118713A1 - Diagnostic compounds - Google Patents

Diagnostic compounds

Info

Publication number
HK1118713A1
HK1118713A1 HK08110335.5A HK08110335A HK1118713A1 HK 1118713 A1 HK1118713 A1 HK 1118713A1 HK 08110335 A HK08110335 A HK 08110335A HK 1118713 A1 HK1118713 A1 HK 1118713A1
Authority
HK
Hong Kong
Prior art keywords
diagnostic compounds
processes
diagnostic
compounds
radiopharmaceuticals
Prior art date
Application number
HK08110335.5A
Other languages
English (en)
Chinese (zh)
Inventor
Magne Solbakken
Bente Arbo
Alan Cuthbertson
Alexander Gibson
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of HK1118713A1 publication Critical patent/HK1118713A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK08110335.5A 2004-09-14 2008-09-18 Diagnostic compounds HK1118713A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0420344.4A GB0420344D0 (en) 2004-09-14 2004-09-14 Diagnostic compounds
PCT/IB2005/002727 WO2006030291A2 (en) 2004-09-14 2005-09-14 Radiofluorinated peptides

Publications (1)

Publication Number Publication Date
HK1118713A1 true HK1118713A1 (en) 2009-02-20

Family

ID=33186989

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08110335.5A HK1118713A1 (en) 2004-09-14 2008-09-18 Diagnostic compounds

Country Status (24)

Country Link
US (2) US7875701B2 (ja)
EP (1) EP1791571B1 (ja)
JP (1) JP4949251B2 (ja)
KR (1) KR101243016B1 (ja)
CN (1) CN101151054B (ja)
AT (1) ATE404225T1 (ja)
AU (1) AU2005283904B8 (ja)
BR (1) BRPI0515175A (ja)
CA (1) CA2578470C (ja)
DE (1) DE602005008996D1 (ja)
DK (1) DK1791571T3 (ja)
ES (1) ES2312018T3 (ja)
GB (1) GB0420344D0 (ja)
HK (1) HK1118713A1 (ja)
IL (1) IL181529A (ja)
MX (1) MX2007003019A (ja)
NO (1) NO20071880L (ja)
NZ (1) NZ553384A (ja)
PL (1) PL1791571T3 (ja)
PT (1) PT1791571E (ja)
RU (1) RU2396272C9 (ja)
SI (1) SI1791571T1 (ja)
WO (1) WO2006030291A2 (ja)
ZA (1) ZA200702700B (ja)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2452923C (en) * 2001-07-10 2012-02-07 Amersham Health As Peptide-based compounds for targeting integrin receptors
EP1985624A3 (en) * 2007-04-23 2008-12-24 Bayer Schering Pharma Aktiengesellschaft Single step method of radiofluorination of biologically active compounds or biomolecules
AU2007294685B2 (en) 2006-09-15 2012-06-07 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
WO2008072976A2 (en) * 2006-12-13 2008-06-19 Ge Healthcare As Synthesis of a radiofluorinated peptide using microwave activation technology
EP2125039A2 (en) 2006-12-18 2009-12-02 GE Healthcare AS Synthesis of a radiofluorinated peptide using photolabile protecting groups
EP2114464A2 (en) * 2006-12-28 2009-11-11 GE Healthcare AS Radiofluorination methods
AU2007348145A1 (en) * 2007-03-01 2008-09-04 Bayer Schering Pharma Aktiengesellschaft 18F fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers
JP5318874B2 (ja) * 2007-09-10 2013-10-16 ジーイー・ヘルスケア・リミテッド 放射性フッ素化方法
US8415510B2 (en) 2008-02-28 2013-04-09 Ge Healthcare Limited Synthesis of a PEG-6 moiety from commercial low-cost chemicals
GB0905438D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Ltd Radiolabelling reagents and methods
US8834839B2 (en) * 2009-04-27 2014-09-16 General Electric Company Labeled molecular imaging agents, methods of making and methods of use
GB0910013D0 (en) * 2009-06-10 2009-07-22 Ge Healthcare Ltd PET imaging of fibogenesis
WO2011084763A1 (en) 2009-12-21 2011-07-14 Ge Healthcare Limited Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f ion
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
KR20130119957A (ko) 2010-12-01 2013-11-01 지이 헬쓰케어 리미티드 방사성 접합 방법
JP6055417B2 (ja) * 2010-12-09 2016-12-27 ジーイー・ヘルスケア・リミテッド 放射性トレーサー組成物
NZ612151A (en) * 2010-12-21 2015-08-28 Ge Healthcare Ltd Use of aniline in the radiostabilization of oxime ligation
US20130074758A1 (en) 2011-09-26 2013-03-28 Ocean Power Technologies, Inc. Anchoring apparatus for wave energy converters
WO2013048956A2 (en) * 2011-09-30 2013-04-04 Ge Healthcare Limited Solid phase extraction separation method
WO2013048996A1 (en) 2011-09-30 2013-04-04 Ge Healthcare Limited Method for the purification of a peptide-based imaging agent precursor
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
KR102205845B1 (ko) 2013-10-28 2021-01-22 삼성전자주식회사 입자에 기반한 모델링 방법 및 장치
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
RU2719399C2 (ru) 2014-12-04 2020-04-17 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ удаления ацетальдегида из радиоактивных фармацевтических препаратов
GB201518918D0 (en) * 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2452923C (en) 2001-07-10 2012-02-07 Amersham Health As Peptide-based compounds for targeting integrin receptors
GB0206750D0 (en) 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0317815D0 (en) * 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
CA2578470A1 (en) 2006-03-23
SI1791571T1 (sl) 2009-02-28
PL1791571T3 (pl) 2009-01-30
BRPI0515175A (pt) 2008-07-08
AU2005283904A1 (en) 2006-03-23
WO2006030291A3 (en) 2007-06-14
JP4949251B2 (ja) 2012-06-06
US20110117016A1 (en) 2011-05-19
ES2312018T3 (es) 2009-02-16
MX2007003019A (es) 2007-08-07
KR20070053750A (ko) 2007-05-25
US20080095701A1 (en) 2008-04-24
EP1791571A2 (en) 2007-06-06
GB0420344D0 (en) 2004-10-13
AU2005283904B2 (en) 2012-01-19
CA2578470C (en) 2015-09-01
NO20071880L (no) 2007-06-13
US7875701B2 (en) 2011-01-25
DE602005008996D1 (de) 2008-09-25
NZ553384A (en) 2011-02-25
ZA200702700B (en) 2008-09-25
CN101151054A (zh) 2008-03-26
EP1791571B1 (en) 2008-08-13
PT1791571E (pt) 2008-11-19
ATE404225T1 (de) 2008-08-15
RU2396272C9 (ru) 2010-12-10
RU2396272C2 (ru) 2010-08-10
KR101243016B1 (ko) 2013-03-12
JP2008516894A (ja) 2008-05-22
WO2006030291A2 (en) 2006-03-23
DK1791571T3 (da) 2008-12-08
RU2007108762A (ru) 2008-10-27
IL181529A (en) 2015-04-30
US8563600B2 (en) 2013-10-22
CN101151054B (zh) 2014-09-24
IL181529A0 (en) 2007-07-04
AU2005283904B8 (en) 2012-02-23

Similar Documents

Publication Publication Date Title
ZA200702700B (en) Diagnostic compounds
CY1118199T1 (el) Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk
PH12013500365A1 (en) Anti-infective agents and uses thereof
TW200732335A (en) Organic compounds
TW200800999A (en) Novel compounds
UA94833C2 (en) Substituted bicyclolactams
TW200745114A (en) Novel compounds
CR10157A (es) Compuestos químicos
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
MX2010004493A (es) Compuestos de tropano.
TW200716529A (en) New compounds II
TW200732337A (en) Organic compounds
TW200745122A (en) New compounds I
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
JO2578B1 (en) Compounds Theophene benzimidazole
TN2009000063A1 (en) Compounds and methods for 18f labeled agents
TW200736227A (en) New compounds III
TW200800986A (en) Tetrahydroquinolines, synthesis thereof, and intermediates thereto
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
WO2009035959A3 (en) Radiofluorination methods
TW200744612A (en) New combination
TW200720262A (en) Novel compounds ii
TN2010000094A1 (en) Novel herbicides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180914